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Cytotoxic and mutagenic effects of thirteen commercial herbal mixtures sold in KwaZulu-Natal, South Africa were evaluated using the neutral
red uptake (NRU) assay and the Ames test. The herbal mixtures tested included Umzimba omubi, Umuthi wekukhwehlela ne zilonda, Mvusa
ukunzi, Umpatisa inkosi, Imbiza ephuzwato, Vusa umzimba, Ingwe® muthi mixture, Ibhubezi™, Supreme one hundred™, Sejeso herbal mixture
Ingwe®, Lion izifozonke Ingwe®, Stameta™ BODicare® and Ingwe® special muti. The relative cytotoxicity of the herbal mixtures was
established by determining their NI50 values (50% inhibition of neutral red uptake). The test revealed that the most toxic herbal mixture was
Umpatisa inkosi with an NI50 value of 0.016 mg/mL and the least toxic mixture was Stameta™ BODicare® with an NI50 value of 28.00 mg/mL.
The herbal mixtures showed no mutagenic effects against Salmonella typhimurium tester strains TA98, TA100, TA102, TA1535 and TA1537
when the assay was done without S9 metabolic activation. However, four herbal mixtures, Umpatisa inkosi, Imbiza ephuzwato, Vusa umzimba
and Stameta™ BODicare® showed mutagenic effects against TA98 but not the rest of the tester strains after using S9 metabolic activation.
Umpatisa inkosi also exhibited weak mutagenic activity against TA1535 after metabolic activation. The remaining mixtures did not show
mutagenic effects against all the tester strains after S9 metabolic activation. The cytotoxic and mutagenic results reported here offer a step toward
determining the safety of commercial herbal mixtures in South Africa. Herbal mixtures showing higher cytotoxic and mutagenic effects need to be
further investigated for their possible effects on humans.
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Herbal mixtures are concoctions of two or more plant species
with the same or different medicinal uses (Cano and Volpato,
2004). These remedies are often well-known in local commu-
nities and are prepared at home for minor ailments such as
insomnia, digestive disorders, coughs, diarrhoea and fever. In
South Africa, commercialisation of such products has resulted
in the production of complex mixtures for many conditions as
well as energy boosters, detoxifiers, immune boosters and
aphrodisiacs. The principle aim of making these herbal mixtures⁎ Corresponding author.
E-mail address: rcpgd@ukzn.ac.za (J. Van Staden).
0254-6299/$ - see front matter © 2009 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2009.09.010seems to be increasing the therapeuticity of a herbal product by
mixing plant species of common or different uses (Cano and
Volpato, 2004).
A growing number of the world's population are turning to
plant derived remedies and medicines for many reasons, which
include their low cost compared to western pharmaceuticals and
seeking natural alternatives which are widely believed to have
fewer side effects. The herbalmedicine (muthi in isiZulu) industry
is a multi million Rand industry in South Africa and is continually
growing. Despite the existence of the Medicines and Related
Substances Control Act 101 of 1965 and its amendments of 2002
(Department of Health, 1965, 2002) it is still difficult to regulate
commercially labelled medicines, herbal formulations and
nutritional supplements. Medicine regulation, is in the public
interest, and comprises three integral aspects: quality, safety andts reserved.
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nation of herbal products used in traditional medicines are a
concern as they are sold on pavements and in markets where the
materials are often exposed to sputum, urine and faeces,
contrasting with the pharmaceutical manufacturing standards
which are necessary for production and packaging of other
medicines (Steenkamp et al., 2006). Regarding efficacy and
safety, it is imperative to evaluate the relative risk from traditional
African herbs and remedies.
Techniques involving in vitro tests are increasingly used as
alternatives to whole animal toxicity tests due to their reduced
use of experimental animals, their low cost, high specificity and
rapidity (Asensio et al., 2007). Cell line methods such as the
neutral red uptake (NRU) assay are used as screening tests for
new therapeutic products to assess acute and chronic toxicity
(Castell and Gómez-Lechón, 1996). The NRU cytotoxicity
assay procedure is a cell survival/viability chemosensitivity
assay based on the ability of viable cells to incorporate and bind
neutral red (NR), a supravital dye. NR is a weak cationic dye
that readily penetrates cell membranes by non-ionic diffusion
and accumulates intracellularly in lysosomes. Alterations of the
cell surface or the sensitive lysosomal membrane leads to
lysosomal fragility and other changes that gradually become
irreversible. Such changes brought about by the action of
xenobiotics result in a decreased uptake and binding of NR. It is
thus possible to distinguish between viable, damaged, or dead
cells, which are the basis of this assay (Barile, 1994; Repetto
et al., 2008).
Healthy mammalian cells, when maintained in culture,
continuously divide and multiply over time. A toxic chemical,
regardless of site or mechanism of action, will interfere with this
process and result in a reduction of the growth rate as reflected by
cell number.Cytotoxicity is expressed as a concentration dependent
reduction of the uptake of the NR after chemical exposure thus
providing a sensitive, integrated signal of both cell integrity and
growth inhibition (Bohets et al., 1993; Repetto et al., 2008).
Damage of the genetic material by environmental mutagens
can lead to mutations in many organisms, including humans.
Mutations are associated with the development of most cancers
and various degenerative disorders and genetic defects in
offspring (Cariño-Cortés et al., 2007). To prevent mutagenic
risk, it is important to identify the involved environmental
mutagens and minimize human exposure to them. Short-term
genetic bioassays like the Ames assay have been used as
important tools in mutagenic studies because of their simplicity,
sensitivity to genetic damage, speed, low cost of experimenta-
tion and small amount of sample required (Mathur et al., 2007).
Poisoning due to plant products (herbal poisoning) is not well
documented because of the unwillingness of people to admit
using traditional medicine derived from plant material and
because of the fear that the cultural heritage of the people will
be put under strong laws and regulations (Steenkamp et al., 2006).
To date several studies have looked at the mutagenic effects of
individual medicinal plants from South Africa (Elgorashi et al.,
2003; Verschaeve et al., 2004; Reid et al., 2006; Verschaeve and
Van Staden, 2008), but not at herbal preparations. This study was
undertaken to evaluate cytotoxic and mutagenic effects of herbalmixtures that are commonly sold in traditional herbal shops in
KwaZulu-Natal, South Africa.
2. Materials and methods
2.1. Sample procurement
Thirteen commercial herbal mixtures, Umzimba omubi,
Umuthi wekukhwehlela ne zilonda, Mvusa ukunzi, Umpatisa
inkosi, Imbiza ephuzwato, Vusa umzimba, Ingwe® muthi
mixture, Ibhubezi™, Supreme one hundred™, Sejeso herbal
mixture Ingwe®, Lion izifozonke Ingwe®, Stameta™ BODi-
care® and Ingwe® special muti were bought at random from
muthi shops around Pietermaritzburg, KwaZulu-Natal accord-
ing to availability. Table 1 includes trade names, uses and
packaging information for the thirteen herbal mixtures. We have
evaluated nine of these herbal mixture for antibacterial,
antifungal effects and the abilities to inhibit the cyclooxygenase
(COX-1 and -2) enzymes (Ndhlala et al., 2009).
2.2. Sample preparation
The herbal mixtures (200 mL) were filtered through What-
man No. 1 filter paper and freeze dried. The dried material was
weighed and resuspended in water and filtered through a sterile
0.22 µm filter unit (Millex® GV, Molsheim, France) to obtain a
sterile 50 mg/mL concentration used with further dilutions in
the concentration-range finding study. For NI50 evaluation (see
below) concentrations and dilutions were prepared based on the
range finding data.
2.3. The neutral red uptake (NRU) assay
The NRU test was done according to Borenfreund and
Puerner (1985). Cell suspension of human hepatocellular liver
carcinoma cell line 2 (HepG2) in Dulbecco's modified Eagle's
culture medium (DMEM) supplemented with 10% foetal calf
serum was seeded into each well of a 96-well microtitre plate
such that the cell density was forty thousand cells/well. Plates
were incubated overnight at 37 °C, 5% CO2 and humidity was
maintained using a water bath containing milli-q water inside
the incubator. After 24 h incubation, the cells were treated with
dilutions of the herbal mixtures and a positive control sodium
dodecyl sulfate (SDS). Cells were kept in the presence of the
test mixture (0, 0.0005, 0.005, 0.05, 0.5, 5 and 50 mg/mL of
each herbal mixture initially and thereafter suitable concentra-
tions were used depending on the preliminary toxicity results)
for another 24 h. At this point the medium was removed and
cells were washed with phosphate-buffered saline (PBS)
solution. Medium (200 µl) containing 0.05 mg/mL neutral red
dye (NR) was added to each well using a multichannel pipette.
The microtiter plates were incubated for 3 h in a humidified 5%
CO2 incubator at 37 °C. The medium was removed and the cells
were rapidly washed with 0.2 mL of PBS solution. An acetic
acid–ethanol mixture (0.2mL) was used to extract the dye from
the cells. The plates were agitated on a microtiter plate shaker
for at least 1 h (or until a homogeneous stained medium was
Table 1
Selected commercial herbal mixtures sold in KwaZulu-Natal, South Africa.
Product name Medicinal uses Directions of use Expiry date Packaging
Trade name Shelf life
Batch number
Umzimba omubi Used to treat wounds, skin rashes,
fungal infections and boils
Not on label Not on label 500 ml
Umuthi wekukhwehlela
ne zilonda
Used as a cough mixture, to treat chest
infections and difficulty in breathing
Not on label Not on label 500 ml
Mvusa ukunzi A ‘man tonic’ for increasing sexual prowess
and can be used as an energiser
Not on label Not on label 500 ml
Umpatisa inkosi An ‘adult tonic’ used for increasing sexual
prowess, as an energiser also used to treat
sexually transmitted diseases (STDs), to
stop menstrual pains, increase appetite, treat
high blood pressure and fight arthritis
Not on label Not on label 500 ml
Imbiza ephuzwato A detoxifying and energising tonic used to
increase sexual prowess, relieve constipation,
reduce stress, reduce high blood pressure,
clear skin conditions, boost energy, boost vitality,
helps to prevent arthritis, kidney problems and
relieve general body pains
¼ cup in the morning
after meals twice a week
Not on label 1 Litre
Vusa umzimba Used to treat wounds, rashes, fungal infections,
boils chest infections, stop menstrual pains,
increase stamina and fight against influenza virus
4 tablespoons twice a day.
Not for children under 14 years
of age and pregnant women
On label 500 ml
Ingwe® 6 months
Batch no. AMM 0016
Ingwe muthi mixture A traditional African mixture for chest infections,
STDs, arthritis, heartburn, relieving constipation
and increasing sexual prowess
3 tablespoons every morning On label 500 ml
Ingwe® 6 months
Batch no. AMM 0011
Ibhubezi™ Used for wounds, fungal infections, STDs,
treatment of influenza, to reverse impotence, clean
the body system and stimulate blood production
¼ cup twice a week. Not for children
under 14 years of age and pregnant
women. Shake well before use
Not on label 500 ml
Supreme one hundred Used for nervous disorders, skin conditions,
stimulates blood production, boost sexual
performance, treats back pains, fights influenza
and strengthens the body
¼ cup every night before sleeping
after meals. Not for children under
14 years of age and pregnant women
On label 500 ml
BODicare® 1 year
Batch no. 05020207
Sejeso herbal mixture Used to relieve heartburn, constipation,
stomach ache, stomach cramps and indigestion
¼ cup three times a day after meals.
Not to be taken by children and
pregnant women
On label 500 ml
Ingwe ® 6 months
AMM 005
Lion izifozonke Used for chest infections, STDs, arthritis,
heartburn, relieving constipation and
increasing sexual prowess
¼ cup three times a day after meals.
Not to be taken by children and
pregnant women
On label 500 ml
Ingwe® 6 months
AMM 003
Stameta™ Used for nervous disorders, skin conditions,
boosts sexual performance, poor blood
quality, high blood pressure. Chest, lung,
kidney infections. Fever and flu. Heart
problems, back pain, persistent tiredness.
Menstrual pain, easy bruising, cleans out bile,
bleeding gums, stomach gas, body sores.
Strengthens bones and boost the immune system.
½ or ¼ cup three or four times a week.
Not for children under 14 years of age and
pregnant women. Drink water after using
Stameta™.
On label 500 ml
BODicare® 1 year
04020207
Ingwe special muti Used for alleviating menstrual pain,
general pain.
Take one 5 ml teaspoon in hot water or with
tea every morning until the course is finished.
Not for children under 14 years of age and
pregnant women.
On label 500 ml
Ingwe® 6 months
AMM 003
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measured at 540 nm using a micro plate spectrophotometer.
For all wells optical density (OD) values were calculated as
the measured value minus the control value (Vc). Results were
expressed as percentage of the OD determined from the average
of the blank control culture read at 540 nm and set at 100%. The
NI50, (50% inhibition of NRU) was determined from the dose
response curve of the mean OD values of the seven
concentrations as indicated.For the positive control a separate plate was used where cells
were treated with different concentrations of SDS and the NI50 was
determined as for the herbal extracts described above. TheNI50was
kept within limits that were determined from 10 independent
experiments from which average NI50 values and standard
deviations were calculated (unpublished data). The calculated
NI50 for the positive control in an experiment should bewithin ±2.5
SD of the historical data for SDS. If this is not the case the results
cannot be accepted and the test should be repeated.
Table 2
NI50 values (mg/mL) after 24 h treatment of HepG2 with herbal test mixtures.
Sample Yield a (mg/mL) NI50 (mg/mL)
Umzimba omubi 2.4×10−6 1.220
Umuthi wekukhwehlela ne zilonda 2.3×10−6 1.010
Mvusa ukunzi 2.9×10−6 1.680
Umpatisa inkosi 2.2×10−4 0.016
Imbiza ephuzwato 2.1×10−5 1.150
Vusa umzimba Ingwe® 5.5×10−6 5.890
Ingwe muthi mixture Ingwe® 5.5×10−6 3.610
Ibhubezi™ 1.1×10−4 15.200
Supreme one hundred BODicare® 9.2×10−5 17.900
Sejeso herbal mixture Ingwe® 0.5×10−5 2.630
Lion izifozonke Ingwe® 5.3×10−6 4.280
Stameta™ BODicare® 1.8×10−4 28.000
Ingwe special muti Ingwe® 6.2×10−6 2.080
SDS (positive control) 0.082
a Yield was obtained by filtering and freeze drying 100 mL portions and the
residue was weighed and expressed as yield (mg/mL).
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Mutagenicity was tested using the Salmonellamicrosome assay
based on the plate-incorporation procedure with Salmonella
typhimurium tester strains TA98, TA100, TA102, TA1535 and
TA1537 with and without metabolic activation (Maron and Ames,
1983; Mortelmans and Zeiger, 2000). TA98 strain has a −1
frameshift mutation at hisD3052which affects the reading frame of
a repetitive base pair –C–G–C–G–C–G–C–G- sequence, TA100
and TA1535 has a hisG46marker resulting from the substitution of
a leucine (GAG/CTC) by a proline (GGG/CCC). The hisG46
mutation can be reverted to awild type bymutations that cause base
pair substitution at theGC site. TA102 containsAT base pairs at the
hisG428 mutant site. The hisG428 can be reverted by mutagens
that cause oxidative damage. TA1537 carries a +1 frameshift
mutation hisC3076 located near the repetitive site –C–C–C-
sequence and can be reverted by frameshift mutagens that are not
readily detected by the hisD3052 (TA98).
Overnight bacterial tester strains were grown in 10mL Oxoid
nutrient brothNo.2 for 16 hat 37 °C toobtain adensity of 1–2×109
colony forming units (CFU/mL). The metabolic activation mixture
(S9 mix) was prepared freshly before the assay and kept on ice
throughout the assay procedure. The S9 mix consisted of 5% (v/v)
S9 fraction (Sigma-Aldrich, Co., St Louis) pooled from Sprague-
Dawleymale rats inmixed enzymic cofactors containingNADP.At
the beginning of the assay, top agar supplemented with 0.5 mM
histidine and biotin was melted and kept in a 50 °C water bath. To
sterile glass tubes, in triplicate, 100 µl of three dilutions (50, 500,
5000 µg/mL) per sample were added, followed by 500 µl
phosphate buffer (0.1 mM, pH 7.4) or S9 mix. To the mixture,
100 µl of the overnight bacterial culture was added followed by
2 mL of the melted top agar. The contents of the tubes were then
mixed and poured onto labelledminimal agar plates. As soon as the
top agar had hardened (2–3 min), the plates were inverted and
incubated at 37 °C for 48 h. The colonies were then counted with
the aid of a binocular microscope. The assay was repeated twice for
each bacterial strain and the results were expressed as the mean
(±standard error) number of revertant colonies per plate. 4-
Nitroquinoline-N-oxide (4NQO) (2 µg/plate) was used as a
positive control for the assay without metabolic activation
while 2-aminoanthracene (2-AA) (2 µg/plate) was used where
the assay was carried out with S9 metabolic activation. Sterile
distilled water was used as a negative control in both assays.
The test herbal mixture/compound was classified as a
‘mutagen’ if the results satisfied two criteria (1) a dose
dependent increase in the number of revertants is observed and
(2) the number of revertants is equal to or greater than two times
that of the negative control.
3. Results and discussion
3.1. The neutral red uptake (NRU) assay
The neutral red uptake inhibition in human liver (HepG2)
cells was used to assess potential toxicity of thirteen commercial
herbal mixtures sold in South Africa. The NRU assay is
important for ranking of toxic components according to theirpotencies and structure–toxicity relationship studies (Bohets
et al., 1993). The NI50 values of the thirteen mixtures are
summarised in Table 2. The results revealed that the most toxic
herbal mixture was Umpatisa inkosi, with an NI50 value of
0.016 mg/mL and a yield of 2.2×10 10−4 mg/mL residue
which implies that 72.72 mL of the herbal mixture will result in
the stated NI50 value (Table 2). The least toxic mixture was
Stameta™ BODicare® with an NI50 value of 28.00 mg/mL and
a yield of 1.8×10−4 mg/mL which implies that 115.56 L of the
mixture is required to reach the NI50 value of the mixture. The
rest of the mixtures exhibited moderate toxicity with NI50
values ranging within the two highlighted values.
HepG2 cells used were from a highly differentiated human
hepatoma cell line that retains many of the cellular functions
often lost by cells in culture. This cell line also has the enzymes
involved in phase I (MFO) and phase II (glucuronic acid and
sulphate conjugation) metabolism of xenobiotics, and it has
been used as an in vitro system instead of human normal
hepatocytes to study drug metabolism and toxicity (Nakama
et al., 1995).
3.2. Ames test
The standard plate incorporation test methods for the Ames
test using Salmonella typhimurium tester strains TA98, TA100,
TA102, TA1535 and TA1537 exposed to three dilutions with
and without S9 metabolic activation of the herbal mixtures was
performed. Ames test without S9 metabolic activation can only
detect direct mutagens while with S9 metabolic activation
allows the detection of indirect mutagens, often caused by
conjugation reactions of metabolic oxidation systems. Table 3
presents the spontaneous reversion response of the Salmonella
typhimurium tester strain to the different dilutions of the herbal
mixtures. The results revealed that all thirteen herbal mixtures
were non-mutagenic towards the Salmonella typhimurium
strains TA98, TA100, TA102, TA1535 and TA1537 for the
assay without metabolic activation. The average His+ revertants
observed for all the tester strains caused by the herbal mixtures
at all the concentrations without metabolic activation did not
Table 3
Number of His+ revertants in Salmonella typhimurium strains TA98, TA100, TA102, TA1535 and TA1537 produced by herbal mixtures with and without S9 metabolic activation.
Sample µg/mL Number of His+ revertants
TA98 TA100 TA102 TA1535 TA1537
S9− S9+ S9− S9+ S9− S9+ S9− S9+ S9− S9+
Umzimba omubi 5000 22.3±0.9 29.0±1.7 157.0±12.6 183.3±10.1 349.3±20.7 277.0±5.8 13.3±1.2 21.3±1.8 6.0±1.7 9.3±0.3
500 21.7±1.7 24.3±3.8 195.0±2.9 234.3±15.7 374.0±26.4 269.0±9.1 14.3±4.5 18.0±0.5 6.7 ±0.6 8.0±0.5
50 26.7±0.9 24.7±0.9 182.7±8.3 202.3±6.6 326.3±31.6 262.3±4.2 12.0±1.5 13.3±0.8 7.0±0.5 7.7±0.6
Umuthi wekukhwehlela ne zilonda 5000 26.0±0.6 21.3±0.7 168.7±4.4 209.7±5.9 331.7±12.8 284.7±6.8 17.0±1.2 33.0±0.5 9.0±0.5 7.7±1.4
500 25.0±1.5 23.0±1.0 173.3±8.9 187.7±5.5 321.6±17.1 275.0±6.1 16.3±0.3 21.7±1.8 8.3±0.3 7.0±0.5
50 23.3±0.9 19.3±0.9 183.0±6.5 188.3±6.1 301.0±2.1 269.3±3.7 14.3±2.4 18.3±0.6 7.7±0.8 6.7±1.2
Mvusa ukunzi 5000 22.7±0.7 19.3±0.3 163.0±4.6 191.0±6.6 306.3±10.1 287.0±1.2 12.0±0.6 21.0±4.5 7.0±0.0 10.0±0.5
500 23.0±0.3 21.0±2.1 178.3±11.4 191.0±7.1 319.0±13.3 257.0±5.0 14.0±0.6 21.3±2.1 8.0±1.0 10.0±0.5
50 25.0±2.0 26.0±4.4 200.3±6.0 198.0±0.6 320.0±2.0 257.0±2.1 17.7±2.6 21.3±0.8 7.7±1.3 8.7±0.3
Umpatisa inkosi 5000 23.3±2.6 219.6±16.3 180.7±8.0 207.0±2.6 281.3±9.3 274.0±1.5 17.0±4.0 96.3±1.7 6.3±0.8 8.3±0.6
500 24.7±0.9 70.6±1.5 183.0±7.6 198.3±0.7 291.3±7.7 264.3±1.2 14.0±0.6 71.0±2.5 6.3±1.4 7.7±0.3
50 25.7±1.2 32.3±4.1 195.3±5.7 200.0±2.1 289.3±6.9 272.3±7.9 15.7±0.9 47.3±2.0 5.7±0.8 7.3±0.3
Imbiza ephuzwato 5000 22.0±0.9 227.7±23.1 171.6±10.1 230.7±1.5 329.6±19.7 256.3±1.9 14.7±1.5 52.0±3.0 7.3±0.3 8.0±1.0
500 24.0±1.6 71.5±5.5 173.7±2.9 194.7±1.8 320.7±50.3 236.3±3.9 15.3±1.5 34.0±1.5 5.0±0.5 9.3±0.3
50 19.7±1.2 45.3±1.8 180.5±4.4 203.7±1.8 299.3±7.2 231.7±0.7 14.0±0.6 22.0±0.5 5.7±0.6 9.7±1.7
Vusa umzimba Ingwe® 5000 23.7±2.7 217.0±26.2 167.7±3.2 191.0±1.2 305.3±1.7 320.3±4.4 13.3±0.9 41.3±0.6 5.7±0.3 8.0±0.1
500 19.3±0.7 106.0±18.0 173.6±9.1 181.3±14.8 314.3±26.5 223.7±1.2 17.0±0.6 32.0±0.5 7.0±0.5 6.7±0.3
50 18.0±1.2 52.7±3.0 182.6±11.5 181.3±9.8 288.7±12.7 209.7±0.7 11.0±0.6 20.3±6.0 6.0±0.5 8.7±0.3
Ingwe muthi mixture Ingwe® 5000 25.0±1.0 32.7±5.2 197.0±9.7 209.0±3.2 350.3±14.1 288.0±0.6 10.3±2.4 21.3±1.2 7.3±0.8 7.3±0.3
500 19.3±1.7 24.0±5.5 185.3±7.2 200.7±0.3 311.3±6.1 269.7±4.2 16.0±4.5 20.7±1.8 7.3±1.2 9.7±0.3
50 20.0±1.0 33.7±8.0 179.7±6.3 207.3±3.8 288.3±5.7 215.7±0.9 12.3±0.9 15.7±2.0 6.0±0.5 8.3±0.6
Ibhubezi™ 5000 23.3±1.3 36.0±2.1 184.6±6.4 179.3±1.8 337.0±7.1 301.3±0.3 16.0±2.5 27.0±0.5 6.0±0.5 7.7±0.3
500 23.0±1.0 39.7±2.7 177.0±5.2 180.3±14.8 319.3±3.9 266.0±6.1 13.7±4.8 19.7±1.7 6.0±0.5 8.0±0.5
50 22.0±1.2 35.3±0.9 181.3±5.9 176.7±11.7 305.0±5.0 258.7±6.9 12.0±1.0 17.0±0.5 6.3±0.8 7.3±0.3
Supreme one hundred BODicare® 5000 28.0±1.5 31.6±6.7 178.0±9.9 223.3±1.5 388.7±12.7 244.0±5.8 12.3±0.3 26.0±0.5 8.0±1.5 7.7±0.8
500 26.0±3.2 31.3±2.3 179.6±11.4 213.3±1.8 322.7±13.3 219.3±6.8 17.0±0.5 25.3±0.3 7.3±0.3 7.3±0.3
50 26.0±1.5 31.0±1.7 176.7±4.1 204.0±2.1 305.0±2.5 206.3±1.8 13.0±2.0 24.3±0.6 6.0±1.5 9.3±1.2
Sejeso herbal mixture Ingwe® 5000 20.0±0.7 23.3±0.9 163.3±25.4 211.7±5.3 307.0±19.4 277.7±6.1 14.3±0.6 25.0±1.5 5.3±0.8 8.3±0.3
500 22.0±0.6 25.0±3.5 155.7±1.8 203.7±0.3 302.3±12.3 255.3±5.8 14.0±1.5 18.3±0.8 5.0±0.5 8.7±1.3
50 20.4±0.2 21.3±1.2 172.6±2.2 203.3±1.2 304.0±4.0 313.0±0.5 17.7±0.6 17.7±0.6 6.3±1.2 8.7±0.3
Lion izifozonke Ingwe® 5000 22.7±1.0 23.7±0.9 177.7±10.1 255.7±4.9 319.0±12.9 316.0±2.5 24.3±0.3 24.3±0.3 7.0±2.0 7.7±0.6
500 23.1±1.7 25.3±3.5 177.7±13.3 235.7±2.9 298.0±13.2 256.0±6.4 22.0±1.5 22.0±1.5 6.3 ±0.8 7.7±0.8
50 21.0±0.2 23.7±0.9 188.6±16.5 203.7±1.5 284.0±3.6 256.0±6.4 13.3±0.3 15.3±1.2 6.7±0.8 8.3±0.3
Stameta™ BODicare® 5000 22.0±2.0 131.3±6.9 172.6±6.9 187.0±15.0 395.3±9.3 257.0±5.5 13.0±0.5 28.0±1.5 6.3±0.3 8.7±0.3
500 22.3±2.0 48.0±3.2 166.3±1.9 135.0±1.0 341.3±10.1 259.0±9.6 13.0±0.5 24.0±0.5 6.3±0.8 8.7±0.3
50 19.0±2.0 39.3±8.0 197.7±4.9 125.3±3.3 325.7±9.5 255.3±5.8 13.3±0.8 17.7±0.6 7.3±1.2 8.7±0.3
Ingwe special muti Ingwe® 5000 21.3±0.3 23.6±2.4 175.0±5.7 173.3±4.2 320.3±6.9 262.0±3.1 11.3±0.3 19.0±0.5 6.7±0.8 10.3±1.2
500 19.0±1.0 24.3±1.9 188.3±2.2 167.0±1.2 344.3±11.3 256.0±6.4 16.0±2.0 18.7±1.4 7.3±0.8 7.7±0.3
50 21.0±0.9 28.0±1.5 204.3±4.5 163.0±3.5 318.7±18.2 247.7±8.8 12.7±1.8 18.3±0.8 7.7±0.6 7.0±0.5
4NQO 2 64.0±0.6 931.7±145.2 2436.3±120.1 1415.7±62.3 65.0±6.9
2–AA 2 218.0±13.4 985.3±113.9 1659.0±51.5 162.3±4.0 128.7±31.4
Water (–ve control) 22.0±1.6 25.3±1.0 199.6±2.3 207.0±4.9 296.0±10.6 16.7±1.4 21.7±1.4 21.7±1.4 6.7±1.2 9.3±0.8
Number of His+ revertants/plate: mean values of three triplicates, the assay was repeated two times.
S9− refers to assay without metabolic activation; S9+ refers to assay with metabolic activation.
4-NQO; 4-nitroquinoline-oxide, positive control for the S9− assays. 2-AA; 2-aminoathracene, positive control for S9+ assays.
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dependent increase in the number of revertants and the numbers
of revertants were all not equal to or greater than two times that
of the negative control (Bulmer et al., 2007). There was also no
decrease in the number of revertant colonies to levels far below
the negative control (spontaneous reversion) which could also
be classified as toxic.
The Ames test with metabolic activation was carried by
addition of the S9 mix so as to detect indirect mutagenic effect
cause by metabolites of the test herbal mixtures. The S9 fraction
contains a mixture of xenobiotic metabolizing enzymes such as
the cytochrome P450s and sulfotransferase. Four of the thirteen
herbal mixtures (Umpatisa inkosi, Imbiza ephuzwato, Vusa
umzimba and Stameta™ BODicare®) showed indirect muta-
genic effect toward the tester strain TA98 after metabolic
activation but not in the other tester strains (TA100, TA102,
TA1535 and TA1537). Umpatisa inkosi, a man tonic induced
219.6, 70.6 and 32.3 TA98 revertant colonies from the highest
to the lowest concentration, with revertant colonies increasing
as the concentration of the mixture increases. However, the
revertant colonies (32.3) induced at the lowest concentration
(50 µg/mL) by Umpatisa inkosi did not satisfy the criteria for
mutagenicity. The mixture also exhibited mutagenic effects
towards TA1535 after metabolic activation. Imbiza ephuzwato,
a multipurpose Zulu herbal tonic induced a high number of
TA98 revertant colonies (227.7, 71.5 and 45.3) while Vusa
umzimba, also a multipurpose herbal mixture induced 217.0,
106, 0 and 52.7 TA98 revertant colonies. The number of
revertant colonies for Imbiza ephuzwato and Vusa umzimba
satisfy the criteria of mutagenicity. Stameta™ BODicare®
exhibited a weak mutagenicity potential against TA98. At the
highest concentration (5000 µg/mL), Stameta™ BODicare®,
induced 131.1 revertant colonies and 48.0 at 500 µg/mL. The
rest of the mixtures did not show any mutagenic potential
against all tester strains after metabolic activation.
TA98 has a −1 frameshift mutation hisD3052 which affects
the reading frame of a repetitive –C–G–C–G–C–G–C–G-
sequence (Mortelmans and Zeiger, 2000). Therefore, the four
herbal mixtures (Umpatisa inkosi, Imbiza ephuzwato, Vusa
umzimba and Stameta™ BODicare®) cause a reversion of the
hisD3052 mutation back to the wild-type state. The herbal
mixtures could contain various aromatic nitroso-derivatives of
amine carcinogens that have been shown to cause such a reversal
of hisD3052 mutation back to the wild-type state.
Some carcinogenic compounds such as aromatic amines or
polycyclic aromatic hydrocarbons like benzo-[a]-pyrene are
biologically inactive unless they are metabolized to active
forms. In humans, xenobiotic metabolizing enzymes present in
the liver, lungs and kidneys, are constantly carrying out
conjugation reactions and in some cases the compounds results
in bioactive metabolites capable of damaging DNA (Mortel-
mans and Zeiger, 2000).
Imbiza ephuzwato contains plants that are known from
previous investigations to possess mutagenic and toxic
constituents (Verschaeve and Van Staden, 2008). Imbiza
ephuzwato, consists of a mixture of 21 plant species consisting
of bulbs, leaves and roots. Most of the 21 plant species thatconstitute Imbiza ephuzwato are used by traditional people to
treat various conditions. For example, Gunnera perpensa or
Ugobo in Zulu, one of the plant constituents of Imbiza
ephuzwato contains bioactive compounds with uteroactive
properties (Brookes and Dutton, 2007). Other plant species in
the same mixture include toxic plants species such as Scadoxus
puniceus, Gomphocarpus fruticosa, Gnidia kraussiana and
Drimia robusta (Van Wyk et al., 2002). Gnidia kraussiana
contains diterpenoids which causes fatalities in both humans
and livestock in various parts of Africa including South Africa.
The plant has been used as a fish poison. Diterpenoids have
antitumour and antileukaemic activities (Van Wyk et al., 2002).
The evaluation of bacterial mutagenicity is important as an
initial test for complex mixtures because of the possibility that one
or more of their components can be a mutagen (Lee et al., 2005;
Déciga-Campos et al., 2007). The fact that some of the tested herbal
mixtures showed no mutagenic effects against all the tester strains
could be due to antagonism on potential toxic compounds which
could be a result of mixing a number of herbs (Leung, 2004).
Recently, there have been reports on increased global
demands for herbal products that act as energy boosters,
detoxifiers, immune boosters and aphrodisiacs (Cherdshewasart
et al., 2008). The results of this study provide evidence to
support the safe consumption of some herbal mixtures at low
and medium doses and also have alerted us to mixtures that
were found to be mutagenic.
Poisoning due to herbal mixtures and/or products most often
occurs in the age group 1–5 years, however, according to
descriptions on most of the labels of the herbal mixtures
(Table 1), the mixtures are not recommended for children under
the age of 14 years. Adult poisoning occur usually as a result of
mislabeling of products, or products which are not stored in
their original containers. Occasionally poisoning is through
confusing or misidentifying a toxic plant with something that is
thought to be edible (Van Wyk et al., 2002). In some instances,
adults could be poisoned by taking incorrect doses or prolonged
use, thus it is also important for the manufactures to clearly state
the directions of use and possible side effects. Also interactions
of these herbal products with western drugs could be lethal as
often patients tend to mix western and traditional medicines.
4. Conclusion
The NRU assay revealed different levels of cytotoxicity
while no mutagenic effects were observed in the thirteen herbal
mixtures without S9 metabolic activation. The question of the
nature of the toxic compounds observed in the NRU assay still
remains unanswered. This calls for further work to identify the
toxins involved. The observed cytotoxic and mutagenic effects
against TA98 after S9 metabolic activation of Umpatisa inkosi,
Imbiza ephuzwato, Vusa umzimba and Stameta™ BODicare®
raises concerns as to the safety of these herbal products. At
present the contents of most of the mixtures are not known.
Further investigation and confirmation needs to be done with
the objective of continuing research to determine and hopefully
eliminate the source of the observed cytotoxic and mutagenic
effects.
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